Aspire BioPharma, Inc. Net Asset Quality Index
Aspire BioPharma, Inc. net asset quality index. Aspire BioPharma, Inc. (ASBP) has a Net Asset Quality Index of 86.8% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $13.54 Million minus total liabilities of $1.78 Million yields net assets of $11.76 Million. A higher index indicates a stronger, lower-leverage balance sheet. See ASBP total equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Aspire BioPharma, Inc. (2021–2025)
Net asset quality index of Aspire BioPharma, Inc. from 2021 to 2025. This chart shows how Aspire BioPharma, Inc.'s Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of June 2026, the index stands at 86.8%, representing net assets of $11.76 Million against total assets of $13.54 Million USD. Check how tangible is Aspire BioPharma, Inc.'s equity to evaluate the tangible quality of the company's equity base.
Aspire BioPharma, Inc. Net Asset Quality Index by Year (2021–2025)
Aspire BioPharma, Inc. net asset quality index by year from 2021 to 2025. The table below presents the year-by-year Net Asset Quality Index for Aspire BioPharma, Inc. from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market cap of Aspire BioPharma, Inc..
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -485.9% | $-6.38 Million | $1.31 Million | $7.69 Million | ▲ +554.7 pp |
| 2024 | -1040.7% | $-1.54 Million | $147.99K | $1.69 Million | ▼ -1138.7 pp |
| 2023 | 98.0% | $19.58 Million | $19.98 Million | $403.33K | ▲ +1.7 pp |
| 2022 | 96.3% | $289.07 Million | $300.18 Million | $11.12 Million | ▲ +96.5 pp |
| 2021 | -0.2% | $-475.00 | $293.22K | $293.70K | — |